10.1002/asia.201901754
Chemistry - An Asian Journal
FULL PAPER
Kubota, J. Kobayashi, Tetrahedron Lett. 1999, 40, 4819–4820; e) J. E.
Baldwin, R. M. Adlington, A. Conte, N. R. Irlapati, R. Marquez, G. J.
Pritchard, Org. Lett. 2002, 4, 2125–2127.
The further complexation of newly synthesized isoxazolidines
leading to the biologically active and pharmaceutically relevant drug
like molecules is currently ongoing in our laboratory.
[8]
[9]
Isoxazolines as a nucleoside analogue, see: U. Chiacchio, A. Corsaro,
D. Iannazzo, A. Piperno, V. Pistarà, A. Rescifina, R. Romeo, V. Valveri,
A. Mastino, G. Romeo, J. Med. Chem. 2003, 46, 3696–3702.
For N-O bond cleavage of isooxazoline, see: a) L. Hu, M. Rombola, V.
H. Rawal, Org. Lett. 2018, 20, 5384−5388.
Experimental Details.
Acknowledgements
[10] X. Zhang, P. Cividino, J.-F. Poisson, P. Shpak-Kraievskyi, M. Y.
Laurent, A. Martel, G. Dujardin, S. Py, Org. Lett. 2014, 16, 1936–1939.
[11] a) J. Hoogenboom, H. Zuilhof, T. Wennekes, Org. Lett. 2015, 17, 5550–
5553; b) C.-Z. Yao, Z.-F. Xiao, X. -S. Ning, J. Liu, X.-W. Zhang, Y. -B.
Kang, Org. Lett. 2014, 16, 5824–5826.
The authors thank, DST-SERB, Government of India, for the
financial support through the research grant: File Nos.
SB/S2/RJN-042/2017 and ECR/2017/002207. Author also
thanks to Jain University, India, for financial support
[12] a) S. M. Lait, D. A. Rankic, B. A. Keay, Chem. Rev. 2007, 107, 767–
796; (b) M. Frederickson, Tetrahedron 1997, 53, 403–425.
[13] Cycloadditions of hydroxylamines with alkenes, Recent selected
examples: a) Y. Kobayashi, Y. Taniguchi, N. Hayama, T. Inokuma, Y.
Takemoto, Angew. Chem. Int. Ed. 2013, 52, 11114–11118; b) C. Gioia,
F. Fini, A. Mazzanti, L. Bernardi, A. Ricci, J. Am. Chem. Soc. 2009, 131,
9614–9615; c) F. Pesciaioli, F. D. Vincentiis, P. Galzerano, G.
Bencivenni, G. Bartoli, A. Mazzanti, P. Melchiorre, Angew. Chem. Int.
Ed. 2008, 47, 8703–8706; d) M. B. Hay, J. P. Wolfe, Angew. Chem. Int.
Ed. 2007, 46, 6492–6494; e) R. L. LaLonde, Z. J. Wang,; M. Mba,; A. D.
Lackner,; F. D. Toste, Angew. Chem., Int. Ed. 2010, 49, 598–601.
[14] Cycloadditions of oxaziridines with olefins or arynes, Recent selected
examples: a) K. M. Partridge, M. E. Anzovino, T. P. Yoon, J. Am. Chem.
Soc. 2008, 130, 2920–2921; b) K. M. Partridge, I. A. Guzei, T. P. Yoon,
Angew. Chem. Int. Ed. 2010, 49, 930–934.
Keywords: regioselective • isoxazolidines • DFT study • nitrone
cycloaddition • metal and ligand free
References:
[1]
a) D.-L. Mo, L. L. Anderson, Angew. Chem. Int. Ed. 2013, 52, 6722–
6725; (b) S. Murarka, A. Studer, Org. Lett. 2011, 13, 2746–2749; c) D.-
L. Mo, W. H. Pecak, M. Zhao, D. J. Wink, L. L. Anderson, Org. Lett.
2014, 16, 3696–3699; d) D.-L. Mo, D. J. Wink, L. L. Anderson, Chem. -
Eur. J. 2014, 20, 13217–13225; e) C. B. Huehls, J. H. Huang, J. Yang,
Tetrahedron. 2015, 71, 3593–3596; f) W. H. Pace, D.-L. Mo, T. W.
Reidl, D. J. Wink, L. L. Anderson, Angew. Chem. Int. Ed. 2016, 55,
9183–9332.
[15] Cycloadditions of O-silyloxime with alkenes, Selected examples: a) N.
Morita, R. Kono, K. Fukui, A. Miyazawa, H. Masu, I. Azumaya, S. Ban,
Y. Hashimoto, I. Okamoto, O. Tamura, J. Org. Chem. 2015, 80, 4797–
4802; b) O. Tamura, T. Mitsuya, H. Ishibashi, Chem. Commun. 2002,
1128–1129.
[2] a) P. H. Poulsen, S. Vergura, A. Monleon, D. Kaare, B. Jorgensen, K. A.
Jørgensen, J. Am. Chem. Soc. 2016, 138, 6412-6415; b) Z. Wang, H.
Zhang, H. Qian, Y. Wang, C. Yu, T. Li, C. Yao, Org. Biomol. Chem.
2019, 17, 4564-4571; c) S. Oh, I. H. Jeong, W. S. Shin, Q. Wang, S.
Lee, Bioorg. Med. Chem. Lett. 2006, 16, 1656–1659; d) F. Cateni, J.
Zilic, M. Zacchigna, P. Bonivento, F. Frausin, V. Scarcia, Eur. J. Med.
Chem. 2006, 41, 192–200; e) J. Liu, S. Zhao, X. Yan, Z. Wang, Y.
Zhang, P. Zhao, W. Fang, K. Zhuo, Y. Yue, Asian J. Org. Chem. 2018,
7, 1565–1570.
[16] Cycloaddition of cyclopropanes with nitrosoarenes: S. Chakrabarty, I.
Chatterjee, B. Wibbeling, C. G. Daniliuc, A. Studer, Angew. Chem. Int.
Ed. 2014, 53, 5964–5968.
[17] Annulation of 2-nitrosopyridine with allylstannanes: I. Chatterjee, R.
Frohlich, A. Studer, Angew. Chem. Int. Ed. 2011, 50, 11257–11260.
[18] Cascade reaction of N-alkoxyazomethine ylides, see: S. Sugita, N.
Takeda, N. Tohnai, M. Miyata, O. Miyata, M. Ueda, Angew. Chem. Int.
Ed. 2017, 56, 2469–2472.
[19] a) I. Ramakrishna, P. Ramaraju, M. Baidya, Org. Lett. 2018, 20, 1023–
1026; b) J. Xie, Q. Xue, H. Jin, H. Li, Y. Cheng, C. Zhu, Chem. Sci.
2013, 4, 1281–1286; c) J. Y. Kang, A. Bugarina, B. T. Connell, Chem.
Commun. 2008, 3522–3524; d) Z. Yin, J. Zhang, J. Wu, C. Liu, K.
Sioson, M. Devany, C. Hu, S. Zheng, Org. Lett. 2013, 15, 3534–3537;
e) T. Yao, B. Ren, B. Wang, Y. Zhao, Org. Lett. 2017, 19, 3135–3138.
[20] Y. Yao, W. Yang, Q. Lin, W. Yang, H. Li, L. Wang, F. Gu, D. Yang, Org.
Chem. Front, 2019, DOI: 10.1039/C9QO00660E.
[3]
For examples see: a) D.-L. Mo, D. J. Wink, L. L. Anderson, Chem. Eur.
J. 2014, 20, 13217–13225; b) M. A. Kroc, M. Markiewicz, W. H. Pace,
D. J. Wink, L. L. Anderson, Chem. Commun. 2019, 55, 2309-2312.
For 1,3 dipolar cycloadditon of nitrone with olefins, see: a) T.
Hashimoto, K. Maruoka, Chem. Rev. 2015, 115, 5366–5412; b) K. V.
Gothelf, K. A. Jorgensen, Chem. Commun. 2000, 1449–1458; c) Nitrile
Oxides, Nitrones and Nitronates in Organic Synthesis: K. G. Torssell,
B.,Ed.; Wiley-VCH: Weinheim, Germany, 1998. d) A. Brandi, S. Cicchi,
F. M. Cordero, A. Goti, Chem. Rev. 2003, 103, 1213–1270; e) L. M.
Stanley, M. P. Sibi, Chem. Rev. 2008, 108, 2887–2902; f) K. V. Gothelf,
K. A. Jørgensen, Chem. Rev. 1998, 98, 863–910; g) P. Appukkuttan, V.
P. Mehtaa, E. V. V. der Eycken, Chem. Soc. Rev. 2010, 39, 1467–1477.
For isoxazoline in bioactive molecules see, e.g.: a) D. G. Piotrowska, J.
Balzarini, I. E. G1owacka, Eur. J. Med. Chem. 2012, 47, 501–509; (b) A.
R. Minter, B. B. Brennan, A. K. Mapp, J. Am. Chem. Soc. 2004, 126,
10504–10505.
[4]
[21] For our previous work with nitrone substrates, see: a) R. B. Dateer, S.
Chang, Org. Lett. 2016, 18, 68–71; b) R. B. Dateer, S. Chang, J. Am
Chem. Soc. 2015, 137, 4908-4911; c) A. Mukherjee, R. B. Dateer, R.
Chaudhuri, S. Bhunia, S. N. Karad, R.–S. Liu, J. Am. Chem Soc.
2011,133, 15372–15375.
[5]
[6]
[22] For hydrolysis of nitrone, see: H. Deng, H. Li, W. Zhang, L. Wang,
Chem. Commun. 2017, 53, 10322–10325.
[23] a) J. Li, M. Zhang, S. Huang, Y. Ding, A. Hu, Asian J. Org. Chem. 2018,
7, 2076–2081; b) H. rard, I. Chataigner, J. Org. Chem. 2013, 78,
9233-9242.
[24] M. A. Chiacchio, L. Legnani, A. Campisi, B. Paola, L. Giuseppe, D.
Iannazzo, L. Veltri, S. Giofrèd, R. Romeod, Org. Biomol. Chem. 2019,
17, 4892-4905.
[25] For our recent work showcasing one-pot synthesis approach, see: A.
Ghosh, R. Hegde, V. B. Makane, B. Sridhar, H. B. Rode, S. A. Patil, R.
B. Dateer, Org. Biomol. Chem. 2019, 17, 4440–4444.
For Isoxazoline as aprecursors for the asymmetric synthesis of natural
products: a) M. S. Wilson, A. Padwa, J. Org. Chem. 2008, 73, 9601–
9609; b) J. K. Gallos, C. I. Stathakis, S. S. Kotoulas, A. E. Koumbis, J.
Org.Chem. 2005, 70, 6884–6890; c) S. Akai, K. Tanimoto, Y. Kanao, S.
Omura, Y. Kita, Chem. Commun. 2005, 2369–2371.
[7]
For isoxazolidines in natural products, see: a) M. Berthet, M. Cheviet, G.
Dujardin, I. Parrot, J. Martinez, Chem. Rev. 2016, 116, 15235–15283;
b) B.-X. Zhao, Y. Wang, D.-M. Zhang, R.-W. Jiang, G.-C. Wang, J.-M.
Shi, X.-J. Huang, W.-M. Chen, C.-T. Che, W.-C. Ye, Org. Lett. 2011, 13,
3888–3891; c) N. Ma, Y. Yao, B.-X. Zhao, Y. Wang, W.-C. Ye, S. Jiang,
Chem. Commun. 2014, 50, 9284–9287; d) M. Tsuda, K. Hirano, T.
4
This article is protected by copyright. All rights reserved.